Robotic eye surgery market seen reaching $2.66 billion by 2030

Robotic-assisted eye surgery is forecast to grow from $1.39 billion in 2025 to $2.66 billion by 2030, driven by demand for more precise, less invasive ophthalmic procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Robotic-assisted eye surgery is moving from a niche capability to a broader ophthalmic tool as demand rises for higher precision, less invasive procedures, and more consistent surgical outcomes. - The growth outlook points to continued investment in eye-care robotics, especially as cataracts, retinal disease, and other eye disorders become more common.

What happened: - The Business Research Company released a market analysis projecting the robotic-assisted eye surgery market will rise from $1.39 billion in 2025 to $1.59 billion in 2026. - The same report forecasts the market will reach $2.66 billion by 2030, representing a 13.7% compound annual growth rate. - North America was the largest regional market in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also published a free sample report and the full market report online: Download a free sample and View the full report.

The details: - Robotic-assisted eye surgery uses robotic systems or instruments to support ophthalmic surgeons in highly precise, less invasive procedures. - The technology is designed to improve dexterity, stability and control during delicate operations involving the retina, cornea and other ocular tissues. - The market’s recent growth has been supported by the limits of manual microsurgery, rising cataract and retinal cases, the expansion of specialized eye-care centers, surgeon demand for precision tools and wider use of computer-assisted ophthalmic technologies. - The forecast is underpinned by AI-powered robotic systems, an aging population, more ambulatory surgical centers, higher R&D spending and wider surgeon acceptance of robot-assisted interventions. - Emerging trends include more minimally invasive procedures, demand for stable and exact outcomes, greater use in complex retinal and corneal surgeries, more surgeon training and a stronger focus on patient safety and lower surgical variability. - The report says increased prevalence of eye disorders remains a key growth driver. - The report links part of that rise to longer screen time, which can contribute to digital eye strain, dry eyes and blurred vision. - The report says robotic-assisted systems can help reduce errors, support faster healing and improve patient outcomes through less invasive surgery. - In May 2024, US Centers for Disease Control and Prevention data showed 20.5 million Americans age 40 and older, or 17.2% of that group, were expected to have cataracts in at least one eye in 2024. - The CDC figure is projected to rise to more than 30 million by 2028.

Between the lines: - The market forecast suggests ophthalmology is joining other surgical fields in adopting robotics where precision matters most. - The report’s emphasis on AI, training and safety points to a market that is still scaling, not fully mature. - Fast growth in Asia-Pacific likely reflects expanding access to advanced eye care and a larger pipeline of patients needing treatment.

What's next: - The market is expected to keep expanding as ambulatory centers, surgeon training and robotic platforms spread. - The 2026 edition of the company’s market reports adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated visuals. - More adoption of robotic-assisted systems is likely if developers continue improving precision and usability for complex ophthalmic procedures.

The bottom line: - Robotic-assisted eye surgery is set for strong growth through 2030 as demand builds for safer, more exact eye procedures and older populations increase the need for treatment.